Etesevimab (JS016) Administered with Bamlanivimab Receives FDA Emergency Use Authorization for COVID-19

NEXT STORY
Update on vaccine production at BioNTech’s manufacturing site in Marburg
PREV STORY
Basilea reports positive topline results from phase 2 study FIDES-01 for derazantinib in FGFR2 gene fusion-positive patients with bile duct cancer (iCCA)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Etesevimab (JS016) Administered with Bamlanivimab Receives FDA Emergency Use Authorization for COVID-19

NEXT STORY
Update on vaccine production at BioNTech’s manufacturing site in Marburg
PREV STORY
Basilea reports positive topline results from phase 2 study FIDES-01 for derazantinib in FGFR2 gene fusion-positive patients with bile duct cancer (iCCA)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Myriad Genetics to Present Multiple Studies on Breast Cancer at the 2019 San Antonio Breast Cancer Symposium

author_avatar
NASDAQ Market News

Merit Medical to Present at 2021 SVB Leerink Global Healthcare Conference

author_avatar
NASDAQ Market News

OPKO Health to Present at the 38th Annual J.P. Morgan Healthcare Conference

author_avatar
NASDAQ Market News